Study of an experimental drug for advanced gynecological and other solid tumors
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests an experimental medicine called SI-B036 for people with advanced gynecological cancers or other solid tumors that have spread. The goal is to see if the drug is safe and how well it might work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have a locally advanced or metastatic gynecological tumor (like ovarian, uterine, or cervical cancer) or another type of solid tumor that has spread.
- You are willing and able to provide a tumor tissue sample (from a previous biopsy or a new one).
- You have at least one measurable tumor (can be seen on scans).
- You are able to do most daily activities (performance status 0 or 1).
- You have not had cancer treatment (like chemo or immunotherapy) in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, SI-B036, for people with advanced head and neck tumors or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and slow the disease.
This trial tests an experimental drug called IBI3020 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective for these patients.
This study tests a new drug called SI-B036 for people with advanced breast cancer or other solid tumors that have spread. The goal is to see if the drug is safe and to find the best dose.
This trial tests a new drug called SI-B036 in people with advanced digestive tract or other solid tumors that have spread. It aims to see if the drug is safe and effective. You may qualify if you have a measurable tumor and are in relatively good health.
This trial tests a new drug (SI-B036) for people with advanced urological tumors or other solid tumors that have spread. The goal is to see if the drug is safe and effective, and it might help shrink tumors or slow their growth.
This early-stage trial tests a new drug called SI-B036 in patients with advanced cancers that have spread or cannot be completely removed by surgery. The goal is to understand how safe the drug is and how well it works.
Hear when a new Gynecological Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.